Sana Biotechnology, Inc. SEC filings SANA
Sana Biotechnology, Inc. has 389 filings in SEC EDGAR's recent list, going back to Jun 26, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 11, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| S-3ASR | Automatic shelf registration | Mar 3, 2026 | — |
| 424B5 | Prospectus supplement | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Aug 6, 2025 | — |
| 424B5 | Prospectus supplement | May 8, 2025 | — |
| S-8 | Employee stock plan registration | May 8, 2025 | — |
| POS AM | Filing | Mar 17, 2025 | — |
| S-8 | Employee stock plan registration | May 8, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 8, 2024 | — |
| FWP | Free writing prospectus | Feb 8, 2024 | — |
| 424B5 | Prospectus supplement | Feb 7, 2024 | — |
| S-8 | Employee stock plan registration | May 8, 2023 | — |
| POS AM | Filing | Mar 16, 2023 | — |
| S-3ASR | Automatic shelf registration | Aug 4, 2022 | — |
| S-8 | Employee stock plan registration | May 10, 2022 | — |
| S-8 | Employee stock plan registration | Jul 30, 2021 | — |
| S-8 | Employee stock plan registration | Feb 8, 2021 | — |
| 424B4 | Prospectus | Feb 5, 2021 | — |
| S-1MEF | Filing | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 2, 2021 | — |
| S-1/A | Amended registration statement | Jan 28, 2021 | — |
| S-1 | Registration statement | Jan 13, 2021 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SANA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1770121
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.